Copyright
©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. Nov 5, 2021; 12(6): 103-112
Published online Nov 5, 2021. doi: 10.4292/wjgpt.v12.i6.103
Published online Nov 5, 2021. doi: 10.4292/wjgpt.v12.i6.103
Table 1 Basic demographics of patients and indications for colon capsule endoscopy, n (%)
| Total | With castor oil | Without castor oil | P value | |
| 186 | 62 | 124 | ||
| Age | 0.2365 | |||
| Mean | 60.0 | 62.0 | 59.0 | |
| Range | 18-97 | 22-97 | 18-86 | |
| Gender | 0.8357 | |||
| Male | 82 (44%) | 28 (45.2) | 54 (43.5) | |
| Female | 104 (56%) | 34 (54.8) | 70 (56.5) | |
| Indications | ||||
| Polyp surveillance | 96 | 30/62 (48.4) | 66/124 (53.2) | 0.5362 |
| Lower gastrointestinal symptoms | 42 | 10/62 (16.1) | 32/124 (25.8) | 0.1382 |
| Incomplete colonoscopy | 28 | 11/62 (17.7) | 17/124 (13.7) | 0.4712 |
| Anaemia | 18 | 10/62 (16.1) | 8/124 (6.5) | 0.0355 |
| IBD surveillance | 2 | 1/62 (1.6) | 1/124 (0.8) | 0.6174 |
- Citation: Semenov S, Ismail MS, O'Hara F, Sihag S, Ryan B, O'Connor A, O'Donnell S, McNamara D. Addition of castor oil as a booster in colon capsule regimens significantly improves completion rates and polyp detection. World J Gastrointest Pharmacol Ther 2021; 12(6): 103-112
- URL: https://www.wjgnet.com/2150-5349/full/v12/i6/103.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v12.i6.103